BrightSpring Health Services, Inc. — fact timeline

Nigam H. Shah was appointed as Director at BrightSpring Health Services, Inc..

“appointed Dr. Nigam H. Shah to the Board as a Class III director to fill the resulting vacancy.”

BrightSpring Health Services, Inc. entered into Underwriting Agreement with KKR Phoenix Aggregator L.P., Management Selling Stockholders, and Goldman Sachs & Co. LLC (effective 2026-06-03).

“On June 3, 2026, BrightSpring Health Services, Inc. (the “Company”) entered into an underwriting agreement with KKR Phoenix Aggregator L.P. (the “KKR Selling Stockholder”), the Management Selling Stockholders (as defined therein) (together with the KKR Selling Stockholder, the “Selling Stockholders”), and Goldman Sachs & Co. LLC (the “Underwriter”), relating to an underwritten offering (the “Offering”) of 14,999,771 shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”), at the public offering price of $58.75 per share.”

BrightSpring Health Services, Inc. shareholders approved Advisory, non-binding vote on the compensation of executive officers. at the 2026-05-21 meeting.

“Item 3 – Advisory, non-binding vote on the compensation of executive officers. Votes FOR Votes AGAINST Votes ABSTAINED BROKER NON-VOTE 179,321,575.79 2,338,742.00 120,774.00 4,675,993.51”

BrightSpring Health Services, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-05-21 meeting.

“Item 2 – Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes FOR Votes AGAINST Votes ABSTAINED BROKER NON-VOTE 186,201,223.30 154,899.00 100,963.00 0”

BrightSpring Health Services, Inc. shareholders approved Election of three Class II directors for a term of office expiring on the date of the annual meeting of stockholders in 2029 and until their respective successors have been duly elected and qualified. at the 2026-05-21 meeting.

“Item 1 – Election of three Class II directors for a term of office expiring on the date of the annual meeting of stockholders in 2029 and until their respective successors have been duly elected and qualified. FOR WITHHELD BROKER NON-VOTE Olivia Kirtley 155,275,089.02 26,506,002.77 4,675,993.51 Max Lin 138,696,145.79 43,084,946.00 4,675,993.51 Steve Miller 139,499,363.02 42,281,728.77 4,675,993.51”

BrightSpring Health Services, Inc. reported the quarter ended March 31, 2026 results: revenue $3,614 million, net income $74 million. Guidance raised.

“EBITDA 1 guidance. First Quarter 2026 Financial Highlights (note: all figures represent continuing operations and exclude the Community Living business) • Net revenue of $3,614 million, up 25.6% compared to $2,878 million in the first quarter of 2025 • Gross profit of $482 million, up 42.5% compared to $338 million in the first quarter of 2025 • Net income of”

BrightSpring Health Services, Inc. completed a disposition involving National Mentor Holdings, Inc. (dba Sevita) for $835 million (closed 2026-03-30).

“On March 30, 2026, upon the terms and subject to the conditions set forth in the Agreement, the Transaction was completed. The aggregate consideration paid to the Company at the closing of the Transaction was $835 million, subject to typical adjustments for working capital and other customary items.”

BrightSpring Health Services, Inc. entered into Underwriting Agreement with KKR Phoenix Aggregator L.P., the Management Selling Stockholders, and Goldman Sachs & Co. LLC (effective 2026-03-02).

“On March 2, 2026, BrightSpring Health Services, Inc. (the "Company") entered into an underwriting agreement with KKR Phoenix Aggregator L.P. (the "KKR Selling Stockholder"), the Management Selling Stockholders (as defined therein) (together with the KKR Selling Stockholder, the "Selling Stockholders"), and Goldman Sachs & Co. LLC (the "Underwriter"), relating to an underwritten offering (the "Offering") of 20,000,000 shares of the Company’s common stock, par value $0.01 per share (the "Common Stock"), at the public offering price of $41.15 per share.”

Michael McMaude resigned as President of Hospice Services and Chief Executive Officer of Abode Healthcare at BrightSpring Health Services, Inc..

“On June 20, 2025, Michael McMaude resigned as the President of Hospice Services of BrightSpring Health Services, Inc. (the “Company”), and the Chief Executive Officer of Abode Healthcare, Inc., a subsidiary of the Company (“Abode”), effective immediately”

Mattingly departed as other_named_officer at BrightSpring Health Services, Inc..

“On April 11, 2025, the Committee approved that certain Severance Agreement, dated as of April 14, 2025, by and between Res-Care, Inc., an affiliate of the Company, and Mr. Mattingly (the “Severance Agreement”), pursuant to which Mr. Mattingly’s employment with the Company terminated on the Transition Date”

Jim Mattingly departed as Chief Financial Officer at BrightSpring Health Services, Inc..

“Ms. Phipps succeeds Jim Mattingly, whose transition and departure was not a result of any disagreement with the Company or any matter relating to the Company’s operations, policies or practices.”

Jennifer Phipps was appointed as Chief Financial Officer at BrightSpring Health Services, Inc..

“Effective on March 4, 2025, Jennifer Phipps, the current Chief Accounting Officer of BrightSpring Health Services, Inc. (the “Company”), was promoted to Chief Financial Officer.”

Matthew D’Ambrosio resigned as Director at BrightSpring Health Services, Inc..

“On November 12, 2024, Matthew D’Ambrosio resigned as a member of the board of directors (the “Board”) of BrightSpring Health Services, Inc. (the “Company”), the Compensation Committee of the Board, and the Quality, Compliance, and Governance Committee of the Board, effective as of November 12, 2024.”

Steven S. Reed retired as Chief Legal Officer at BrightSpring Health Services, Inc..

“As of October 11, 2024, Steven S. Reed, the Chief Legal Officer and Corporate Secretary of BrightSpring Health Services, Inc. (the “Company”), has made the decision to retire from his position after over twenty years of service with the Company, first as a director, and the final eleven years as Chief Legal Officer.”

Dr. Steve Miller was appointed as Class II director at BrightSpring Health Services, Inc..

“On September 27, 2024, the board of directors (the “Board”) of BrightSpring Health Services, Inc. (the “Company”) increased the number of directors serving on the Board from seven (7) to eight (8) members and appointed Dr. Steve Miller to the Board as a Class II director to fill the resulting vacancy.”

BrightSpring Health Services, Inc. reported first quarter ended March 31, 2024 results: revenue $2,577 million, net income Net loss of $46 million. Guidance raised.

“today announced financial results for the first quarter ended March 31, 2024, and increases 2024 revenue and Adjusted EBITDA 1 guidance. Financial Highlights • Net Revenue of $2,577 million, up 27.0% compared to $2,028 million in the first quarter of 2023. • Net loss of $46 million, compared to net loss of $22 million in the first quarter of 2023. • Adjusted EBITDA”

Timothy A. Wicks was appointed as Class I Director at BrightSpring Health Services, Inc..

“appointed Timothy A. Wicks to the Board as a Class I director”

BrightSpring Health Services, Inc. updated its fourth quarter and full year ended December 31, 2023 guidance (reaffirmed).

“On February 29, 2024, BrightSpring Health Services, Inc. issued a press release announcing its financial results for the quarter and year ended December 31, 2023.”

BrightSpring Health Services, Inc. amended credit facility of $2,566,000,000 with Morgan Stanley Senior Funding Inc. as administrative agent and collateral agent at Term SOFR or base rate plus applicable margin; Term SOFR margin for Term Loans i maturing Term Loans mature on February 21, 2031; revolving loans mature on June 30, 2028.

“agent and collateral agent. The Amendment provides for the establishment of a new tranche of term loans (the “ Term Loans ”) in an aggregate principal amount equal to $2,566,000,000, the proceeds of which will be used to refinance an equivalent amount of term loans outstanding under the Credit Agreement immediately before giving effect to the Amendment. The”

BrightSpring Health Services, Inc. entered into Joinder Agreement and Amendment No. 7 to First Lien Credit Agreement with Morgan Stanley Senior Funding Inc. valued at $2,566,000,000 Term Loans (new tranche established, refinancing prior term loans) (effective 2024-02-21).

“On February 21, 2024, Phoenix Intermediate Holdings Inc. (“ Holdings ”) and Phoenix Guarantor Inc. (the “ Borrower ”), each a wholly-owned subsidiary of BrightSpring Health Services, Inc. (“ BrightSpring ”), entered into the Joinder Agreement and Amendment No. 7 (the “ Amendment ”) to the First Lien Credit Agreement, dated as of March 5, 2019 (as amended by the Technical Amendment, dated May 13, 2019, as supplemented by the Joinder Agreement, dated as of September 30, 2019, as amended by Amendment No. 1, dated as of January 30, 2020, as amended by the Joinder Agreement and Amendment No. 2, dated as of June 30, 2020, as amended by the Joinder Agreement and Amendment No. 3, dated as of October 7, 2020, as amended by Amendment No. 4, dated as of April 8, 2021, as amended by the Joinder Agreement and Amendment No. 5, dated as of April 16, 2021 and as amended by the Joinder Agreement and Amendment No. 6, dated as of June 30, 2023, the “ Credit Agreement ”, and as amended by the Amendment, t”

BrightSpring Health Services, Inc.: Amended and Restated Bylaws became effective concurrently with the Charter (effective 2024-01-30).

“on January 30, 2024, the Company’s Second Amended and Restated Certificate of Incorporation (the “ Charter ”), in the form previously filed as Exhibit 3.1 to the Registration Statement, and the Company’s Amended and Restated Bylaws (the “ Bylaws ”), in the form previously filed as Exhibit 3.2 to the Registration Statement, became effective.”

BrightSpring Health Services, Inc.: Second Amended and Restated Certificate of Incorporation became effective, setting authorized capital stock at 1.5B common and 250M preferred shares (effective 2024-01-30).

“on January 30, 2024, the Company’s Second Amended and Restated Certificate of Incorporation (the “ Charter ”), in the form previously filed as Exhibit 3.1 to the Registration Statement, and the Company’s Amended and Restated Bylaws (the “ Bylaws ”), in the form previously filed as Exhibit 3.2 to the Registration Statement, became effective.”

Olivia Kirtley was elected as Director at BrightSpring Health Services, Inc..

“On January 25, 2024, effective immediately following the pricing of the Common Stock Offering, Olivia Kirtley was elected to serve as a new member of the Company’s Board, as the chair of the Audit Committee, and as a member of the Quality & Compliance and Governance Committee.”